Vaxart, Inc. promotes global health through developing vaccines that can be administered via tablet rather than by injection and providing for the efficient, simple administration and distribution of safe vaccines. As an employer, Vaxart has offered full-time, remote jobs in the past. The company is looking for entrepreneurial-minded professionals that are enthusiastic about transforming how vaccines are delivered worldwide. Vaxart prides itself on the dedication of its passionate and bright team members who thrive within a highly collaborative, fast-paced environment.

Founded in 2004, Vaxart is headquartered in San Francisco, California. The company’s goal is to “keep healthy people healthy” and improve the ease of vaccine development, distribution, access, and administration. Vaxart operates with the core belief that vaccines administered by oral tablet instead of injection could dramatically improve patient acceptance and increase global vaccination rates. The company’s vaccine delivery platform delivers recombinant, protein-based vaccines, enabling it to develop oral versions of current vaccines and design and redesign vaccines for new indications. Vaxart is currently developing tablet vaccines to protect against coronavirus, seasonal influenza, norovirus, respiratory syncytial virus, and more. The company has filed broad international and domestic patents for its proprietary technology and oral vaccination creations.

Vaxart, Inc. promotes global health through developing vaccines that can be administered via tablet rather than by injection and providing for the efficient, simple administration and distribution of safe vaccines. As an employer, Vaxart has offered full-time, remote jobs in the past. The company is looking for entrepreneurial-minded professionals that are enthusiastic about transforming how vaccines are delivered worldwide. Vaxart prides itself on the dedication of its passionate and bright team members who thrive within a highly collaborative, fast-paced environment.

Founded in 2004, Vaxart is headquartered in San Francisco, California. The company’s goal is to “keep healthy people healthy” and improve the ease of vaccine development, distribution, access, and administration. Vaxart operates with the core belief that vaccines administered by oral tablet instead of injection could dramatically improve patient acceptance and increase global vaccination rates. The company’s vaccine delivery platform delivers recombinant, protein-based vaccines, enabling it to develop oral versions of current vaccines and design and redesign vaccines for new indications. Vaxart is currently developing tablet vaccines to protect against coronavirus, seasonal influenza, norovirus, respiratory syncytial virus, and more. The company has filed broad international and domestic patents for its proprietary technology and oral vaccination creations.